Abstract
A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have